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BACKGROUND
Liver Carcinoma (LC) is the third most prevalent cause
of cancer-related death worldwide.1 The incidence of
LC is found to be 16 to 32 times higher in developing
countries than in developed countries.1,2 Globally
550,000 to 600,000 new LC cases occur each year, and
it is a leading cause of cancer death in sub-Saharan
Africa with Mozambique having the highest incidence.1
The incidence is generally more in Africa and South
East Asia where HBV and HCV infections are
prevalent particularly for hepatocellular carcinoma
(HCC) while cholangiocarcinoma (CCC) is commoner
in areas with high prevalence of Clonorchis Sinensis and
Clonorchis viverrini.3, 4
In the African population, the age-standardized
incidence of HCC is as high as 41.2/100,000 persons/
year.1 Hepatocellular carcinoma affects male-female in
ratio 4:1 globally, with 1:1 among those without
cirrhosis, 9:1 in high incidence countries while CCC is
commoner in females.5
There is a dearth of epidemiological studies on the
disorder; however, the available studies showed that
the disease constitutes a significant portion in
gastroenterology consultations or malignancies that are
encountered in Africa.6,7 Out of the 4,568 deaths
recorded in the medical wards of UCH, over 14 years
(1960-1973) liver diseases were the third most
common cause of death accounting for 12.1% of all
deaths while PLCC was responsible for 42.5% of liver
diseases related deaths.8 Liver cancer accounted for
44.3% of liver diseases admission at University of
Nigeria Teaching Hospital, Nsukka.9
The disease constitutes a significant financial/economic
burden on the affected patients, families, and caregivers
generally, institutions and the society at large. While the
exact figure of burden may not be known for Nigeria,
the examination of the demographic pattern of this
disease and health service utility would aid health system
planning and development in this environment, since
the burden of LC is expected to increase in the near
future especially without implementing adequate
preventive action.10 Furthermore, this exercise has a
significant epidemiological value while serving as a
clinical audit tool in the institution.
This cross-sectional study determines the basic
demographic characteristics; explores the case
outcomes and examines the temporal profile of LC
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ABSTRACT
Background: Liver Cancer (LC) is a common malignancy globally, and it exacts
an enormous toll on the health care system. Therefore, it is imperative to have an
epidemiological profile for effective planning.
Methods: This study examined the basic demographic, admission profile and
outcome of  this category of  patients through a retrospective cross-sectional study.
The study was carried out using data of clinical diagnoses of LC admitted into
the Gastro-intestinal Unit (GLU), Department of Medicine, University College
Hospital, Ibadan between 1st January 2011 and 31st December 2014.
Results: Two hundred and six patients (16.8%) had diagnoses of LC out of the
1228 total cases admitted by the GLU. The total male patients were 147(71.4%) and
female 59 (28.6%) while the most prominent age group for both genders and
males were 41-50 years in the male group and 51-60 years among females. The
mean + SD and median hospital stay was 10.6±11.6 days and eight days for LC
patients, respectively. The intrahospital fatality rate was 37.9% and occurred mainly
within five days of admission.
Conclusion: Liver Cancer is an important disorder in gastrointestinal practice
and had high fatality within a few days of admission; hence, efforts should be
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patients admitted into the male and female medical
wards in University College Hospital (UCH), Ibadan.
METHODS
The study was a retrospective cross-sectional study of
the case notes of the patients (diagnosed with LC)
admitted into Gastroenterology/Liver Unit (GLU),
Medicine Department of UCH, Ibadan between 1st
January 2011 and 31st December 2014. The patients
were admitted through the Emergency Department,
Medical Out-patient Department, and the Gastroente-
rology/Liver Specialty clinic into designated GLU of
the Medical Wards.
Subjects
A total of 206 patients with diagnoses of LC admitted
consecutively into the wards under the GLU were
included in this study. Basic demographic data such as
age, gender, and unique identification of patients with
diagnoses of cases, dates of admission and discharge,
and in-patient admission outcomes as entered in the
ward record book, were utilized.
Data acquisition and statistical analyses
Data storage was managed with Microsoft Excel 2010
and analyzed with Statistical Package for Social Sciences
version 23 (SPSS Inc, Chicago, IL). The statistical
significance was set at p-value <0.05.
Continuous variables were summarized as mean and
standard deviation, while the categorical variables were
summarized as proportions and frequencies. The data
were illustrated in tables and a figure.
RESULT
The total patients admitted into GLU’s wards were
1,228, with 206 (16.8%) having LC. Table 1 shows the
socio-demographic characteristics of  the participants.
Most participants were males accounting for 147
patients (71.4%).
The age range was 17-85 years with a mean +SD age
of  49.1 ± 15.2 years. The age group with the highest
burden was 41-50 years (27%) among the patients
although 51-60 years (25.4%) and 41-50 years (29.3%)
among the females and male patients respectively (Table
1).
The mean ages of the LC patients were not significantly
higher among the males than females, p=0.1888 and,
most of patients presented below 50 years of age
(62%).
Years Male Female Total
Age (Mean) 52.8±14.4 50.9±17.5 -
Age (Range) 17-85 21-85 17-85
Age Group N N N (%)
< 20 3 0 3(2)
21-30 13 9 22(11)
31-40 37 8 45(22)
41-50 43 12 55(27)
51-60 28 15 43(20)
61-70 14 7 21(10)
71-80 7 6 13(6)
>80 2 2 4(2)
Total 147 59 206
Table 1: Age group and sex distribution among 206
patients with LC admitted into Gastrointestinal/Liver
Unit Wards, UCH; Ibadan; 2011-2014.
Gender Male (147) Female (59) Total (206)
Range(days) 1-119 1-35 1-119
Mean(days) 11±13.1 9.8±6.4 10.6±11.6
0-5 37 29 35
6-10 20 27 22
11-15 14 22 18
16-20 9 10 9
21-25 7 3 6
>26 5 2 4
No Record 8 7 6
Total 100 100 100
Table 2: Percentage distribution of Hospital stay
among 206 patients with LC admitted into
Gastrointestinal/Liver Unit Wards, UCH; Ibadan;
2011-2014
The mean hospital stay was 10.6±11.6 days, and the
longest day of  119 days was observed (Table 2). The
median hospital stay was eight days. The male patients
with LC spent longer days on admission compared
to their female counterparts though not statistically
significant (p-value= 0.542). The peak hospital stay was
0 to 5 days in 72 patients (35%), as shown in Table 2.
Eighty male and 88 female patients spent less than 21
days in the hospital (p-value = 0.323).
Regarding the treatment outcome, discharged home,
discharged against Medical advice (DAMA) and death
occurred in 85(41.3%), 27(13.1%) and 78(37.9%)
respectively, Table 3. Only three patients (1.5%) were
transferred out for surgical care.
The relationship between days on admission and
outcome among the patients with LC (Table 3) showed
that a high number DAMA, had home discharges and
deaths within 0-5days. However, 79.2% of  the 78
deaths among the patients were within 15 days of
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admission while DAMA took place throughout the
admission of patients with LC.
Although the patients had shorter days on admission
through death (p=<0.0001), there was no statistical
difference in the gender distribution of the patterns
of  outcome among them, Figure 1. Also, 151 (73.3%)
of the 206 patients with LC were out of admission
with 15 days.
DISCUSSION
The determination of  basic demographic features of
patients with LC has epidemiological value in the clinical
setting while the clinical outcome and duration of
hospital stay are essential in prognosticating diseases.
Such study also serves as clinical audit tool in a health
institution.
In this study, LC constitutes 18% and was the highest-
ranking admission in the years under review. This
burden was like the findings from previous studies.8, 9
This is not unusual considering that LC is one of the
most prevalent malignancies globally, Nigeria
inclusive.11 The country still has one of the highest
frequencies in the world.12 In other centres across
Nigeria, LC constituted 19.1 % of  all cancers in Port
Harcourt, 17% in Maiduguri and Ilorin, 38.8% of all
cancers of the digestive system.1, 13
The male: female ratio (2.5:1) was found among the
patients with LC and this is similar to studies in Tanzania,
Port Harcourt, Jos and Ile-Ife where the ratio of  2.2:
1, 2:1, 2:1 and 2:1 were found respectively among cases
studied.14 However, the ratio we found is much higher
than the finding in a study of 227 liver biopsies over
Fig. 1: Gender distribution and outcome of  hospital admission of  patients with Liver Cancer GIT/Liver Unit
Wards, UCH; Ibadan, 2011-2014.






0-5 26(30.6) 31(40.2) 0 12(44.5) 3(21.5)
6-10 24(28.2) 16(20.8) 0 5(18.5) 1(7.1)
11-15 11(12.9) 14(18.2) 0 7(25.9) 1(7.1)
16-20 11(12.9) 6(7.8) 0 2(7.4) 0
21-25 7(8.3) 5(6.5) 0 0 0
>26 5(5.9) 4(5.2) 0 0 0
No Record 1(1.2) 2(1.3) 3(100) 1(3.7) 8(64.3)
Total 85(100) 78(100) 3(100) 27(100) 13(100)
Table 3: Relationship between days on admission with outcome among the 206 patients with LC admitted
into GIT/Liver Unit Wards, UCH; Ibadan, 2011-2014.
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the ten years in Jos.14 The difference could be secondary
to the fact that our diagnosis is predominantly clinical
compared to histology in the Jos study. The gender
differences in the prevalence of LC, with male
predominance, have been demonstrated in previous
studies.11, 15 16
Majority of our patients were between 40-70 years
for both genders though males had malignancy at a
younger age. The mean age in this study is similar to
43.7 years that was described previously in Enugu.9
The age range of 17-85 years in this study for LC is
similar to a Yemini study where 26-75 years was found
while previous studies in Nigeria found 35 to 73 years,
23 to 75 years and 35 to 73 years.14,17,18 This has serious
socioeconomic implication considering the productive
capacity of  these age groups. While the disease is usually
as a result of predisposing factor such as hepatitis B
virus infection which could have occurred earlier in
life, it is therefore imperative that preventive efforts
such as childhood Hepatitis B vaccination should be
actively encouraged.
A Tanzanian study of  142 patients, the overall median
duration of hospital stay was 14 days and, both higher
than what we obtained.2 Also, the average duration of
hospital stays of 10.6±11.6 days was without statistical
gender difference in the outcome of  our patients.
Although the mean duration of hospital stay is higher
than a similar study in Nigeria.19
A study in Enugu also had a higher proportion of LC
mortality but a lower proportion of  DAMA.20 The
differential timing of presentation may explain this
mortality in the two centres. Furthermore, late
presentation and poor prognosis of the disease may
generally have contributed to this unsatisfactory
finding.2, 19 Discharge against medical advice is likely to
vary in different population due to sociocultural and
health behaviour characteristics obtainable in different
populations. The high proportion of  discharge home
in our study calls for the palliation of the patients on
an out-patient basis with the participation of relations
in their holistic care, a treatment approach that is highly
encouraged for the care of advanced state cancer
patients.
The intra-hospitality mortality rate of 37.9 % among
the studied patients with LC and three-quarter of them
having their fatal outcome within fifteen days of
admission call for availability of  more intervention and
preventive tools in this environment. Although this
mortality rate is lower than a previous study carried
out in Tanzania.2 It, however, corroborates the poor
outcome and scourge of liver cancer among Nigerians
just as in other Africans and thus calls for the institution
of  surveillance activity towards early diagnosis of  the
tumours.21, 22
CONCLUSION
Liver cancer constitutes about one fifth and makes the
highest-ranking admission of the diseases seen at in-
patient Gastroenterology/Hepatology Unit at our
centre. The mortality rate is high among the LC patients
due to its poorer prognosis and late presentation. Our
study has re-emphasized the predominance of LC
diagnoses among the males compared to females. A
high rate of  DAMA found for the diseases might
reflect the lack of adequate funds for care and fear of
possible outcomes.
Further studies would be needed to be carried out to
further elucidate on the specific pattern of clinical
diagnoses aided by advanced investigative tools and
the possible reasons for the high DAMA rate observed
among our patients.
Limitation of study
The weakness of this study is mainly that the data are
derived from the clinical diagnosis in the ward registers,
which are prone to error by those entering the data
and not purposely developed for this study.
Furthermore, the histological types and staging of  LC
were not included in this report.
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